ARCEVA 40/240MG TAB

Arceva 40/240mg Tablet is a combination medication containing erlotinib and gefitinib, designed for targeted cancer therapy. This dual-action formulation works by inhibiting specific protein kinases involved in tumor cell growth and proliferation. Commonly prescribed for patients with non-small cell lung cancer (NSCLC) expressing particular genetic mutations, Arceva offers a precision medicine approach to treatment. Each tablet delivers a carefully balanced dose to optimize therapeutic efficacy while supporting treatment compliance. Store at room temperature away from moisture and light. Always use as directed by your healthcare provider.